Ranđelović Sara, Bipat Robbert
Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Niš, Serbia.
Department of Physiology, Faculty of Medical Science, Anton de Kom University of Suriname, Paramaribo, Suriname.
Clin Med Insights Endocrinol Diabetes. 2021 Sep 14;14:11795514211042023. doi: 10.1177/11795514211042023. eCollection 2021.
Worldwide, type 2 diabetes mellitus accounts for a considerable burden of disease, with an estimated global cost of >800 billion USD annually. For this reason, the search for more effective and efficient therapeutic anti-diabetic agents is continuing. Coumarins are naturally derived and synthetic molecules with a wide variety of biological actions. The most common application of these molecules in medicine is for their thrombostatic activity. This study aims to give an overview of the current knowledge about the applicability of these chemical products in the therapeutic strategy against diabetes and its complications.
For this purpose, we searched internet databases for publications and abstracts in English that investigated the effects of coumarins or coumarin-like agents with potential anti-diabetic activity.
The result is that a variety of these agents have proven in , , and simple animal models to possess properties that may reduce the glucose absorption rate in the intestines, increase the level of insulin, increase the cellular uptake of glucose or reduce the gluconeogenesis. In addition, some of these agents also reduced the level of glycation of peptides in diabetic animal models and showed antioxidant properties.
In conclusion, we can summarize that coumarins and their related derivatives may be potential antidiabetic agents. Useful formulations with appropriate pharmacokinetic and pharmacodynamic properties must be developed and tested for their efficacy and toxicity in comprehensive animal models before they can enter clinical trials.
在全球范围内,2型糖尿病造成了相当大的疾病负担,估计全球每年的花费超过8000亿美元。因此,人们一直在寻找更有效且高效的抗糖尿病治疗药物。香豆素是天然衍生和合成的分子,具有多种生物活性。这些分子在医学上最常见的应用是其止血活性。本研究旨在概述有关这些化学产品在抗糖尿病及其并发症治疗策略中的适用性的现有知识。
为此,我们在互联网数据库中搜索了英文出版物和摘要,这些文献研究了具有潜在抗糖尿病活性的香豆素或香豆素样药物的作用。
结果表明,在体外、体内和简单动物模型中,多种此类药物已被证明具有可能降低肠道葡萄糖吸收率、提高胰岛素水平、增加细胞对葡萄糖的摄取或减少糖异生的特性。此外,其中一些药物还降低了糖尿病动物模型中肽的糖基化水平,并显示出抗氧化特性。
总之,我们可以总结出香豆素及其相关衍生物可能是潜在的抗糖尿病药物。在进入临床试验之前,必须开发具有适当药代动力学和药效学特性的有用制剂,并在综合动物模型中测试其疗效和毒性。